Table 2.
Distribution of diagnoses by sex
| Diagnosis | Female n (%) |
Male n (%) |
P-value* |
|---|---|---|---|
| Anterior uveitis, undifferentiated | 73 (26.3) | 53 (24.9) | 0.755 |
| Trauma | 40 (14.3) | 20 (9.4) | 0.098 |
| Viral | |||
| Herpetic anterior uveitis | 30 (10.8) | 9 (4.2) | 0.011 |
| Acute retinal necrosis | 9 (3.2) | 4 (1.9) | 0.408 |
| CMV uveitis | 2 (0.7) | 2 (0.9) | 1.000 |
| Herpetic panuveitis | 1 (0.4) | 0 (0.0) | 1.000 |
| Post-procedural uveitis | 21 (7.6) | 28 (13.1) | 0.048 |
| Anterior uveitis HLA-B27 | 18 (6.5) | 15 (7.0) | 0.857 |
| Sarcoidosis | 17 (6.1) | 16 (7.5) | 0.588 |
| Intermediate uveitis | 11 (4.0) | 8 (3.8) | 1.000 |
| Panuveitis, undifferentiated | 11 (4.0) | 12 (5.6) | 0.397 |
| Others | 8 (2.9) | 11 (5.2) | 0.240 |
| Infectious, nonviral | |||
| Toxoplasma | 8 (2.9) | 6 (2.8) | 1.000 |
| Fungal | 3 (1.1) | 1 (0.5) | 0.637 |
| Syphilis | 1 (0.4) | 0 (0.0) | 1.000 |
| Tuberculosis | 1 (0.4) | 0 (0.0) | 1.000 |
| Posterior uveitis, undifferentiated | 6 (2.2) | 3 (1.4) | 0.738 |
| White dot syndrome | |||
| Birdshot | 5 (1.8) | 2 (0.9) | 0.704 |
| MEWDS | 2 (0.7) | 1 (0.5) | 1.000 |
| Multifocal choroiditis | 1 (0.4) | 8 (3.8) | 0.012 |
| APMPPE | 1 (0.4) | 3 (1.4) | 0.321 |
| Serpiginous | 1 (0.4) | 2 (0.9) | 0.582 |
| Seronegative SpA | |||
| Ankylosing spondylitis | 2 (0.7) | 3 (1.4) | 0.657 |
| Crohn’s disease | 2 (0.7) | 2 (0.9) | 1.000 |
| Ulcerative colitis | 1 (0.4) | 1 (0.5) | 1.000 |
| Reactive arthritis | 1 (0.4) | 0 (0.0) | 1.000 |
| Psoriatic arthritis | 0 (0.0) | 1 (0.5) | 0.434 |
| Eales disease | 1 (0.4) | 0 (0.0) | 1.000 |
| Collagen vascular disease | |||
| Polyarteritis nodosa | 1 (0.4) | 0 (0.0) | 1.000 |
| Granulomatosis with polyangiitis | 0 (0.0) | 1 (0.5) | 0.434 |
| Total | 279 (100.0) | 214 (100.0) | 0.066# |
Notes:
*
Fisher’s exact test on 2×2 table, eg, female vs male compared on sarcoidosis vs all other diagnoses.
#
Fisher’s exact test applied to entire table, using Monte Carlo sampling (P=0.085).
Abbreviations: APMPPE, acute posterior multifocal placoid pigment epitheliopathy; CMV, cytomegalovirus; HLA, human leukocyte antigen; MEWDS, multiple evanescent white dot syndrome; seronegative SpA, seronegative spondyloarthropathy.